Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
Metrics to compare | OIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOILPeersSector | |
---|---|---|---|---|
P/E Ratio | −21.8x | −2.0x | −0.5x | |
PEG Ratio | −0.99 | −0.02 | 0.00 | |
Price/Book | 9.4x | 2.6x | 2.6x | |
Price / LTM Sales | 21.9x | 2.4x | 3.1x | |
Upside (Analyst Target) | - | 143.5% | 48.6% | |
Fair Value Upside | Unlock | 22.9% | 8.9% | Unlock |